Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Garmin stock (GRMN) sits at $285.94, down 0.31% today. The business is worth $55.14B in the market, good for #295 of 800 on our coverage list.
Over a full year the shares have ranged across $183.64 to $313.07, which puts the current price roughly 79% of the way up that band.
Revenue for the quarter ended Jun 2026 was $2.02B, up 11.4% from a year earlier, with $541.92M of net profit (a 24.5% margin).
Buyers are paying 29.5 times trailing earnings, 26% above its five-year average of 23.5. The median for its industry group is 33.3.
4 analysts follow the stock and the average call is "buy". The mean target, $320.67, sits 12.1% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 4 factors below, ranked against the 800 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
4 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
GRMN is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $320.67, 12.1% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $231.00, so shares trade 23.8% above that estimate. On earnings multiple, it sits in the 92nd percentile of its own five-year valuation range (pricier than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 1, 2026 12:30 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 29.5x earnings, GRMN looks expensive against the market, and trades 11% below the 33.3x median among Scientific & Technical Instruments names. The two comparisons do not always agree.
$285.94 is the latest print for GRMN, a move of -0.31% against yesterday's close of $286.84. Today's low and high so far: $285.10 and $288.76.
Equity value comes to $55.14B at the current price. By that measure it is number 295 of the 800 names in our coverage.
Buyers pay 29.5 times the last twelve months of profit (EPS $8.59). Averaged over five years the multiple has been 23.5, and today's level ranks in the 92nd percentile of its own history.
The year's floor is $183.64 and the ceiling $313.07. Shares are 8.7% away from that ceiling.
It does. Payouts over the past twelve months work out to a 1.31% yield; the latest ex-dividend date was September 11, 2026.
Of 4 analysts, 25% say buy, 75% hold and 0% sell. Price targets average $320.67, with the most cautious at $295.00 and the most optimistic at $370.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on GRMN.